These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
492 related articles for article (PubMed ID: 26916892)
1. Systemic Juvenile Idiopathic Arthritis: Diagnosis and Management. Kumar S Indian J Pediatr; 2016 Apr; 83(4):322-7. PubMed ID: 26916892 [TBL] [Abstract][Full Text] [Related]
2. Update on the pathogenesis and treatment of systemic idiopathic arthritis. Sikora KA; Grom AA Curr Opin Pediatr; 2011 Dec; 23(6):640-6. PubMed ID: 22045308 [TBL] [Abstract][Full Text] [Related]
3. Systemic juvenile idiopathic arthritis: New insights into pathogenesis and cytokine directed therapies. Pardeo M; Bracaglia C; De Benedetti F Best Pract Res Clin Rheumatol; 2017 Aug; 31(4):505-516. PubMed ID: 29773270 [TBL] [Abstract][Full Text] [Related]
4. Complications of systemic juvenile idiopathic arthritis: risk factors and management recommendations. Woerner A; von Scheven-Gête A; Cimaz R; Hofer M Expert Rev Clin Immunol; 2015 May; 11(5):575-88. PubMed ID: 25843554 [TBL] [Abstract][Full Text] [Related]
6. Systemic onset juvenile idiopathic arthritis: a single center experience. Sağ E; Uzunoğlu B; Bal F; Sönmez HE; Demir S; Bilginer Y; Özen S Turk J Pediatr; 2019; 61(6):852-858. PubMed ID: 32134578 [TBL] [Abstract][Full Text] [Related]
8. Systemic JIA: new developments in the understanding of the pathophysiology and therapy. Vastert SJ; Kuis W; Grom AA Best Pract Res Clin Rheumatol; 2009 Oct; 23(5):655-64. PubMed ID: 19853830 [TBL] [Abstract][Full Text] [Related]
9. Current understanding of the pathophysiology of systemic juvenile idiopathic arthritis (sJIA) and target-directed therapeutic approaches. Bruck N; Schnabel A; Hedrich CM Clin Immunol; 2015 Jul; 159(1):72-83. PubMed ID: 25956529 [TBL] [Abstract][Full Text] [Related]
10. Systemic Juvenile Idiopathic Arthritis. Lee JJY; Schneider R Pediatr Clin North Am; 2018 Aug; 65(4):691-709. PubMed ID: 30031494 [TBL] [Abstract][Full Text] [Related]
12. Proinflammatory Cytokine Environments Can Drive Interleukin-17 Overexpression by γ/δ T Cells in Systemic Juvenile Idiopathic Arthritis. Kessel C; Lippitz K; Weinhage T; Hinze C; Wittkowski H; Holzinger D; Fall N; Grom AA; Gruen N; Foell D Arthritis Rheumatol; 2017 Jul; 69(7):1480-1494. PubMed ID: 28296284 [TBL] [Abstract][Full Text] [Related]
13. The Systemic Juvenile Idiopathic Arthritis Cohort of the Childhood Arthritis and Rheumatology Research Alliance Registry: 2010-2013. Janow G; Schanberg LE; Setoguchi S; Hasselblad V; Mellins ED; Schneider R; Kimura Y; J Rheumatol; 2016 Sep; 43(9):1755-62. PubMed ID: 27307527 [TBL] [Abstract][Full Text] [Related]
14. Reversal of Sepsis-Like Features of Neutrophils by Interleukin-1 Blockade in Patients With Systemic-Onset Juvenile Idiopathic Arthritis. Ter Haar NM; Tak T; Mokry M; Scholman RC; Meerding JM; de Jager W; Verwoerd A; Foell D; Vogl T; Roth J; Leliefeld PHC; van Loosdregt J; Koenderman L; Vastert SJ; de Roock S Arthritis Rheumatol; 2018 Jun; 70(6):943-956. PubMed ID: 29426067 [TBL] [Abstract][Full Text] [Related]
15. Experiences with IL-1 blockade in systemic juvenile idiopathic arthritis - data from the German AID-registry. Lainka E; Baehr M; Raszka B; Haas JP; Hügle B; Fischer N; Foell D; Hinze C; Weissbarth-Riedel E; Kallinich T; Horneff G; Windschall D; Lilienthal E; Niehues T; Neudorf U; Berendes R; Küster RM; Oommen PT; Rietschel C; Lutz T; Weller-Heinemann F; Tenbrock K; Heubner GL; Klotsche J; Wittkowski H Pediatr Rheumatol Online J; 2021 Mar; 19(1):38. PubMed ID: 33752669 [TBL] [Abstract][Full Text] [Related]
16. Advances in the pathogenesis and treatment of systemic juvenile idiopathic arthritis. Correll CK; Binstadt BA Pediatr Res; 2014 Jan; 75(1-2):176-83. PubMed ID: 24213625 [TBL] [Abstract][Full Text] [Related]
17. Pathogenesis of systemic inflammatory diseases in childhood: "Lessons from clinical trials of anti-cytokine monoclonal antibodies for Kawasaki disease, systemic onset juvenile idiopathic arthritis, and cryopyrin-associated periodic fever syndrome". Yokota S; Kikuchi M; Nozawa T; Kanetaka T; Sato T; Yamazaki K; Sakurai N; Hara R; Mori M Mod Rheumatol; 2015 Jan; 25(1):1-10. PubMed ID: 24842480 [TBL] [Abstract][Full Text] [Related]
18. Natural Killer Cells in Systemic Autoinflammatory Diseases: A Focus on Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome. Vandenhaute J; Wouters CH; Matthys P Front Immunol; 2019; 10():3089. PubMed ID: 32010140 [TBL] [Abstract][Full Text] [Related]
19. Interleukin-6 in juvenile idiopathic arthritis. Akioka S Mod Rheumatol; 2019 Mar; 29(2):275-286. PubMed ID: 30686091 [TBL] [Abstract][Full Text] [Related]